These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1999935)

  • 1. Comparison of two levels of anticoagulant therapy in patients with substitute heart valves.
    Altman R; Rouvier J; Gurfinkel E; D'Ortencio O; Manzanel R; de La Fuente L; Favaloro RG
    J Thorac Cardiovasc Surg; 1991 Mar; 101(3):427-31. PubMed ID: 1999935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves.
    Altman R; Boullon F; Rouvier J; Raca R; de la Fuente L; Favaloro R
    J Thorac Cardiovasc Surg; 1976 Jul; 72(1):127-9. PubMed ID: 1084448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with moderate intensity anticoagulation and aspirin after mechanical valve replacement. A retrospective, non-randomized study.
    Albertal J; Sutton M; Pereyra D; Segura EV; Aramburu DF; Lardani H; Diaz R
    J Heart Valve Dis; 1993 May; 2(3):302-7. PubMed ID: 8269123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipyridamole-aspirin as thromboembolic prophylaxis in patients with aortic valve prosthesis. Prospective study with the Model 2320 Starr-Edwards prosthesis.
    Brott WH; Zajtchuk R; Bowen TE; Davia J; Green DC
    J Thorac Cardiovasc Surg; 1981 Apr; 81(4):632-5. PubMed ID: 7206773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major hemorrhagic and thromboembolic complications in patients with mechanical heart valves receiving oral anticoagulant therapy.
    Trzeciak P; Zembala M; Poloński L
    Heart Surg Forum; 2010 Apr; 13(2):E80-5. PubMed ID: 20444682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.
    Ribeiro PA; Al Zaibag M; Idris M; Al Kasab S; Davies G; Mashat E; Wareham E; Al Fagih M
    J Thorac Cardiovasc Surg; 1986 Jan; 91(1):92-8. PubMed ID: 3941564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
    Yamak B; Iscan Z; Mavitas B; Ulus AT; Katircioglu SF; Tasdemir O; Bayazit K
    J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP).
    Pengo V; Palareti G; Cucchini U; Molinatti M; Del Bono R; Baudo F; Ghirarduzzi A; Pegoraro C; Iliceto S;
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):241-8. PubMed ID: 17636186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of a moderate with moderate-high intensity oral anticoagulant treatment in patients with mechanical heart valve prostheses.
    Pengo V; Barbero F; Banzato A; Garelli E; Noventa F; Biasiolo A; Zasso A; Dalla Volta S
    Thromb Haemost; 1997 May; 77(5):839-44. PubMed ID: 9184389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal oral anticoagulant therapy in patients with mechanical heart valves.
    Cannegieter SC; Rosendaal FR; Wintzen AR; van der Meer FJ; Vandenbroucke JP; Briët E
    N Engl J Med; 1995 Jul; 333(1):11-7. PubMed ID: 7776988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial.
    Aramendi JI; Mestres CA; Martinez-León J; Campos V; Muñoz G; Navas C
    Eur J Cardiothorac Surg; 2005 May; 27(5):854-60. PubMed ID: 15848326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.
    Goldsmith I; Lip GY; Mukundan S; Rosin MD
    J Heart Valve Dis; 1998 Sep; 7(5):574-9. PubMed ID: 9793859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors.
    Brueck M; Kramer W; Vogt P; Steinert N; Roth P; Görlach G; Schönburg M; Heidt MC
    Eur J Cardiothorac Surg; 2007 Jul; 32(1):108-12. PubMed ID: 17449264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral anticoagulant treatment with and without aspirin.
    Altman R; Rouvier J; Gurfinkel E
    Thromb Haemost; 1995 Jul; 74(1):506-10. PubMed ID: 8578514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late incidence and determinants of stroke after aortic and mitral valve replacement.
    Ruel M; Masters RG; Rubens FD; Bédard PJ; Pipe AL; Goldstein WG; Hendry PJ; Mesana TG
    Ann Thorac Surg; 2004 Jul; 78(1):77-83; discussion 83-4. PubMed ID: 15223407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of thromboembolism with ticlopidine shortly after valve repair or replacement with a bioprosthesis.
    Aramendi JL; Agredo J; Llorente A; Larrarte C; Pijoan J
    J Heart Valve Dis; 1998 Nov; 7(6):610-4. PubMed ID: 9870193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin anticoagulation in children with mechanical aortic valves.
    Verrier ED; Tranbaugh RF; Soifer SJ; Yee ES; Turley K; Ebert PA
    J Thorac Cardiovasc Surg; 1986 Dec; 92(6):1013-20. PubMed ID: 3784585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of warfarin versus antiplatelet therapy in patients with a St. Jude Medical valve in the aortic position.
    Hartz RS; LoCicero J; Kucich V; DeBoer A; O'Mara S; Meyers SN; Michaelis LL
    J Thorac Cardiovasc Surg; 1986 Oct; 92(4):684-90. PubMed ID: 3762199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advantages of a cardiologic ambulatory care facility specifically organized for patients undergoing treatment with oral anticoagulant drugs].
    Pengo V; Peruzzi P; Marzari A; Zanon F; Banzato A; Schivazappa L
    G Ital Cardiol; 1989 Dec; 19(12):1125-8. PubMed ID: 2561357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.